Objective-The purpose of this study was to determine the role of smooth muscle cell-derived hypoxia-inducible factor-1α (Hif-1α) in the pathogenesis of aortic aneurysms. Approach and Results-Control mice and smooth muscle cell-specific hypoxia-inducible factor-1α-deficient mice were infused with β-aminopropionitrile for 2 weeks and angiotensin II for 6 weeks to induce aortic aneurysm formation. Mutant mice experienced increased levels of aneurysm formation of the thoracic or abdominal aorta with more severe elastin disruption, compared with control mice. Smooth muscle cell-specific hypoxia-inducible factor-1α deficiency did not affect matrix metalloproteinase-2 activity; however, the activity of lysyl oxidase and the levels of tropoelastin mRNA in the angiotensin II-and β-aminopropionitrile-treated aortae, associated with elastin fiber formation, were suppressed. Furthermore, we observed reduced volumes of mature cross-linked elastin in the thoracoabdominal aorta after treatment with angiotensin II and β-aminopropionitrile.
A ortic aneurysmal lesions exhibit fragmentation and disruption of elastic laminas, inflammatory cell infiltration, and loss of vascular smooth muscle cells (VSMCs) with aortic wall expansion. 1, 2 Elastic lamina plays key roles in maintaining the elasticity of aortae; therefore, the disruption of elastin fiber is a major cause of aortic aneurysm formation. Degradation of elastin fiber, one of the extracellular matrix, is mainly caused by induction of matrix metalloproteinase (MMP)-2 or MMP-9 from VSMCs and inflammatory cells. 3 However, dysfunction of elastin fiber maturation causes matrix failure, contributing significantly to aneurysm formation.
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Tropoelastin, an uncross-linked soluble form of elastin, is a major component of elastin fiber. Elastin haploinsufficiency reduces the volume of the elastin cross-linking structure desmosine and enhances elastin fiber fragmentation. 4 Fibrillin-1 is a major component of the microfibrils that form a sheath surrounding elastin; mutations in the fibrillin-1 gene cause Marfan syndrome, which is characterized by matrix failure, and links to aneurysm formation. 5 Lysyl oxidase (LOX) is a crucial enzyme involved in elastin cross-linking and elastin coacervation; inactivation of the LOX gene leads to aortic aneurysms. 6 Additionally, studies involving the administration of the LOX inhibitor β-aminopropionitrile (BAPN) to adult rat or mouse models of aortic aneurysm 7, 8 indicate that the mechanisms underlying elastin fiber formation, especially elastin crosslinking, protect against aortic wall expansion in mature aortae.
Our previous report showed that smooth muscle cell-specific hypoxia-inducible factor-1α (Hif-1α) deficiency suppressed angiotensin II (Ang II)-induced medial thickening by suppressing VSMC hypertrophy and vascular fibrosis via decreased aortal mRNA expression of extracellular matrix-related genes, such as collagen I. 9 However, it remains unclear whether suppression of vascular remodeling and extracellular matrix metabolism is a protective compensatory reaction against vascular vulnerability, which occurs in response to chronic exogenous stimuli. Here, we investigated the role of smooth muscle cell-derived Hif-1α in pharmacologically induced aortic aneurysms, using a mouse model of vascular vulnerability. Our results indicate that deficiency of smooth muscle cell-derived Hif-1α augments aortic aneurysms, accompanied by disruption of elastin fiber formation, but not changes of elastin fiber degradation.
Results
Chronic administration of Ang II and BAPN caused higher incidence of aortic aneurysm (thoracic aortic aneurysm or abdominal aortic aneurysm) formation in smooth muscle cellspecific Hif-1α-deficient mice (SMKO mice) than in control mice; 13% of SMKO mice died as a result of ruptured aortic aneurysms after Ang II and BAPN administration, whereas the control mice did not die during 6-week administration period ( Figure 1A ). Thoracic aortic aneurysms were formed in the ascending aorta, aortic arch, or descending aorta, whereas abdominal aortic aneurysms were consistently formed above the right renal artery in both control mice and SMKO mice ( Figure 1B ; Figure I in the online-only Data Supplement). Five of the 9 thoracic aortic aneurysms in SMKO mice, which occurred after Ang II and BAPN administration, formed in the descending aortic region, 3 in the aortic arch and 1 in the ascending aortic region. Two of the 4 thoracic aortic aneurysms in the control mice formed in the descending aortic region, the third in the aortic arch and the fourth in the ascending aortic region. Elastic van Gieson staining and Azan staining showed that Ang II and BAPN administration caused aortic expansion, elastin breaks, and fibrosis in aneurysmal areas in both groups ( Figure 1C ; Figure II and Figure III in the online-only Data Supplement). The outer diameter of the thoracic aortae was significantly larger in SMKO mice than that in control mice ( Figure IV in the online-only Data Supplement). Visualization of elastic van Gieson staining in high-power fields, as well as electron micrographs of abdominal aortae, indicated that a higher level of fragmentation and disruption of elastic laminas occurred in SMKO mice, after Ang II and BAPN administration, than in control mice ( Figure 1D ). Electron microscopy additionally revealed the loss of VSMCs and cytoplasmic vacuolization in these cells in SMKO mice after the administration of Ang II and BAPN. In the present study, Hif-1α mRNA expression in the aorta was induced by Ang II and BAPN administration, and this expression was reduced in SMKO mice ( Figure V in the online-only Data Supplement). In addition, smooth muscle cell-specific Hif-1α deficiency did not affect blood pressure elevation ( Figure VI in the online-only Data Supplement), suggesting that smooth muscle cellderived Hif-1α plays a protective role against aortic aneurysm formation via mechanisms that are independent of changes in blood pressure.
The administration of Ang II and BAPN elicited elastin breaks not only in thoracic aorta and abdominal aorta but also in thoracoabdominal aorta, although aortic aneurysms were not formed in this region (Figure 2A ). This observation supported the disruption of elastin fiber as a critical contributor to aortic expansion when blood pressure is elevated. The degree of disruption of elastin fiber in the thoracoabdominal aorta in SMKO mice, after Ang II and BAPN treatment, was greater than that in control mice subjected to the same treatment ( Figure 2A ; Figure VII in the online-only Data Supplement). Additionally, the volume of total elastin (insoluble cross-linked elastin and soluble uncross-linked elastin) in the aortae of SMKO mice treated with Ang II and BAPN was lower than in those of control mice undergoing the same treatment ( Figure 2B ). These results indicate that Ang II-induced and BAPN-induced disruption of elastin fiber in the aortae of SMKO mice was more severe than that in control mice.
Gelatin zymography showed that 1 week after administration of Ang II and BAPN, there was no difference in MMP-2 activity in the aortae of control mice and SMKO mice ( Figure VIII in the online-only Data Supplement). MMP-2 and MMP-9 mRNA expression was induced in the aortae of control mice but not in those of SMKO mice, 6 weeks after administration of Ang II and BAPN ( Figure IX in the onlineonly Data Supplement). In addition, the mRNA expression of the macrophage marker, F4/80, was induced in the aortae of control mice but not in those of SMKO mice ( Figure X in the online-only Data Supplement). On the contrary, tropoelastin mRNA expression in the aorta of SMKO mice treated with Ang II and BAPN was lower than that in control mice subjected to the same treatment ( Figure 2C ). In vitro cell culture analysis additionally showed that VSMCs from SMKO mice exhibited lower tropoelastin mRNA expression than those from control mice at day 21 ( Figure XI in the online-only Data Supplement). Additionally, the activity of the enzyme required for tropoelastin cross-linking in the aorta (LOX) was lower in SMKO mice than that in control mice ( Figure 2D ). Inverted black-and-white micrographs of elastic van Gieson staining showed that the volume of elastin fiber, in the form of mature cross-linked elastin, measured in the aortic media of SMKO mice treated with Ang II and BAPN was lower than in those of control mice undergoing the same treatment ( Figure 2E and 2F; Figure XII in the online-only Data Supplement). Although smooth muscle cell-specific Hif-1α deficiency affected the Ang II-induced and BAPN-induced mRNA expression of LOX and LOXL-1, other genes implicated in elastin fiber formation were not affected ( Figure XIII in the online-only Data Supplement). Additionally, LOX mRNA expression in the aortae of SMKO mice was lower than in those of control mice, even 1 week after administration ( Figure XIV in the onlineonly Data Supplement). These results suggest that deficiency of smooth muscle cell-derived Hif-1α augments aortic aneurysms, accompanied by disruption of elastin fiber formation, but not changes of elastin fiber degradation.
Discussion
The major finding of this study was that smooth muscle cell-specific Hif-1α deficiency elicited an increase in the formation of pharmacologically induced aortic aneurysms by suppressing elastin expression and cross-linking. We first demonstrated that Ang II-induced and BAPN-induced disruption of elastin fiber formation in the aortae of SMKO mice was more severe than in the aortae of control mice; however, no difference in MMP activity was observed between the groups 1 week after treatment. In addition, Ang II-and BAPN-induced mRNA expression of MMP-2 and MMP-9 in the aortae was suppressed in SMKO mice. This result is consistent with those of previous studies showing that MMP-2 expression is regulated by Hif-1α. The expression of tissue inhibitors of metalloproteinase-3, which suppresses activity of MMPs, 10 was unchanged in both groups ( Figure IX in the online-only Data Supplement). In addition, there was no difference in the expression of inflammation-related genes between the groups after 6 weeks. These results suggest that deficiency of smooth muscle cell-derived Hif-1α augments aortic aneurysms, accompanied by disruption of elastin fiber formation, but not changes of elastin fiber degradation. Tropoelastin, which is the major source of elastin fiber, binds to elastin-binding protein on the cell surface of VSMCs. Elastin-binding protein stabilizes tropoelastin and transports tropoelastin aggregates to adjacent microfibrils involved in elastin fiber assembly. 11 LOX catalyzes elastin cross-linking and coacervation to produce mature elastin fiber. 12 Our results show that smooth muscle cell-specific Hif-1α deficiency suppressed tropoelastin and LOX mRNA expression in the aortae of mice treated with Ang II and BAPN and reduced LOX activity in the aorta but did not affect the expression of other genes associated with elastin fiber formation. These data indicate that smooth muscle cell-derived Hif-1α is essential for tropoelastin expression and elastin fiber formation, which is promoted by elastin cross-linking, in the medial area ( Figure  XVIII in the online-only Data Supplement). These results were supported by the observation of reduction in the level of mature cross-linked elastin, even in the thoracoabdominal aortic region, which did not experience aortic aneurysm formation, in SMKO mice treated with Ang II and BAPN relative to control mice (Figure 2E and 2F; Figure XII in the online-only Data Supplement). Aortic aneurysm formation had not been observed in SMKO mice that were not subjected to Ang II and BAPN treatment, despite decreased levels of LOX activity in the aorta. Untreated SMKO mice exhibited high level of tropoelastin mRNA expression as a LOX substrate, indicating that its high tropoelastin expression may be sufficient to maintain normal elastin cross-linking activity, despite the low levels of LOX enzyme activity. The high levels of tropoelastin mRNA expression in the aortae of SMKO mice compared with those observed in the control mice may be attributable to a compensatory reaction to the lower levels of LOX enzyme activity. Furthermore, this could explain the discrepancy between the levels of tropoelastin mRNA expression in untreated aortae and untreated VSMCs of SMKO mice. Several previous studies suggested that the disruption of other crucial matrix proteins, such as collagen or fibronectin, is also linked to aortic aneurysm formation. 13, 14 The induction of collagen I mRNA expression in the aortae of control mice, but not in those of SMKO mice, suggests that lower levels of collagen I expression might also contribute to aortic aneurysm formation in the latter. Fibronectin expression did not affect aortic aneurysm formation in SMKO mice ( Figure XV in the online-only Data Supplement) in the present study. We also found that the lower α-smooth muscle actin (SMA)-positive vascular area in abdominal aortic aneurysmal sections of SMKO mice treated with Ang II and BAPN accompanied with greater incidence of aortic aneurysm, relative to the control ( Figure XVI in the online-only Data Supplement). Because VSMC apoptosis has previously been shown to be a factor in aneurysm formation by multiple groups, 15, 16 this result may reflect the reduced number of VSMCs in aneurysmal regions in SMKO mice. However, we could not confirm so many apoptotic VSMCs in abdominal aortic aneurysmal regions in control mice and SMKO mice in this model (data not shown). We supposed that VSMC apoptosis also contributes to aneurysm formation, but it does not play a huge role in the exacerbation of aneurysm formation in SMKO mice. The result of α-SMA immunostaining is accorded with our previous report of suppressed Ang II-induced medial thickening and suppressed Ang II-induced VSMC hypertrophy in SMKO mice. 9 We found cytoplasmic vacuolization in the VSMCs of aneurysmal regions in SMKO mice, but we could not elucidate whether that morphological change linked to a cause of aortic aneurysm formation or was an aortic structural abnormality accompanied with aortic aneurysm formation. The lack of difference in the expression of neovascularization-related genes mRNA expression between control mice and SMKO mice suggests that neovascularization did not contribute to aortic aneurysm formation in the latter ( Figure XVII in the online-only Data Supplement).
Recently, several studies have suggested that hypoxic conditions and the induction of Hif-1α during aneurysms contribute to MMP activation, 17 and Hif-1α contributes to arterial aneurysm formation via abnormal matrix metabolism involving MMP activation and inflammation. 18 Our results of MMP mRNA expression in aortae of SMKO mice were consistent with those observed in these previous studies. However, our results directly suggest that smooth muscle cell-derived Hif-1α protects against aneurysm formation. Furthermore, we think that this protection is provided by tropoelastin expression and LOX expression and activation, rather than by MMP activation and inflammation ( Figure XVIII in the online-only Data Supplement). Our findings indicate that Hif-1α induction in the medial area represents a potential therapeutic strategy for the prevention of aortic aneurysm formation, progression, and rupture.
